2022
DOI: 10.3390/molecules27113494
|View full text |Cite
|
Sign up to set email alerts
|

Personalized Medicine in Mitochondrial Health and Disease: Molecular Basis of Therapeutic Approaches Based on Nutritional Supplements and Their Analogs

Abstract: Mitochondrial diseases (MDs) may result from mutations affecting nuclear or mitochondrial genes, encoding mitochondrial proteins, or non-protein-coding mitochondrial RNA. Despite the great variability of affected genes, in the most severe cases, a neuromuscular and neurodegenerative phenotype is observed, and no specific therapy exists for a complete recovery from the disease. The most used treatments are symptomatic and based on the administration of antioxidant cocktails combined with antiepileptic/antipsych… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
18
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 30 publications
(18 citation statements)
references
References 248 publications
(438 reference statements)
0
18
0
Order By: Relevance
“…Importantly, tissue levels of acetylcarnitine can be increased by oral supplementation 51 with L-carnitine or acetylcarnitine 52 , thus providing an avenue for influencing mitochondrial function, myocardial flexibility and energetics.…”
Section: Discussionmentioning
confidence: 99%
“…Importantly, tissue levels of acetylcarnitine can be increased by oral supplementation 51 with L-carnitine or acetylcarnitine 52 , thus providing an avenue for influencing mitochondrial function, myocardial flexibility and energetics.…”
Section: Discussionmentioning
confidence: 99%
“…Acetylcarnitine influences protein function and gene expression by serving as an acetyl donor 50 for acetylation of mitochondrial/cytosolic proteins and histones. Importantly, tissue levels of acetylcarnitine can be increased by oral supplementation 51 with l ‐carnitine or acetylcarnitine, 52 thus providing an avenue for influencing mitochondrial function, myocardial flexibility, and energetics.…”
Section: Discussionmentioning
confidence: 99%
“…For MELAS syndrome, there is a lack of evidence-based medicine on the effectiveness of drug therapy. Clinicians often use coenzyme Q10, vitamin B1, vitamin C, vitamin E, idebenone, riboflavin, lipoic acid, glutathione, L-carnitine, aspartic acid, folic acid, and taurine in combination to treat MELAS syndrome, known as “cocktail therapy”[ 8 ].…”
Section: Discussionmentioning
confidence: 99%